Case Series: Cemiplimab and Nivolumab Immunotherapy as Promising Treatment in Advanced or Metastatic Cutaneous Squamous Cell Carcinoma

被引：0
|
作者：
Lai, Fei Ya [1 ]
Clarke, Rachel [1 ]
Cooper, Patrick [2 ]
Stokes, John [3 ]
Calvert, Paula [1 ]
机构：
[1] Univ Hosp Waterford, Oncol Dept, Waterford, Ireland
[2] Univ Hosp Waterford, Radiol Dept, Waterford, Ireland
[3] Univ Hosp Waterford, Ophthalmol Dept, Waterford, Ireland
来源：
CASE REPORTS IN ONCOLOGY | 2023年 / 16卷 / 01期
关键词：
Cutaneous squamous cell carcinoma; Cutaneous oncology; Dermatology; Metastatic cutaneous squamous cell carcinoma; Immunotherapy; Immunotoxicities; Immune checkpoint inhibitors;
D O I：
10.1159/000533759
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Cutaneous squamous cell carcinoma (CSCC) is the second most common skin cancer. Surgery is usually curative; however, some locally advanced or metastatic CSCC may be unresectable. Current novel therapeutic options with immune checkpoint inhibition (ICI) of programmed-death receptor 1 (PD-1) such as cemiplimab and nivolumab have demonstrated promising and sustained results with good tolerability in patients with CSCC. This study looks at 2 cases of CSCC treated with cemiplimab and nivolumab, respectively, demonstrating dramatic response within 2 cycles with significant reduction in tumour size and minimal toxicities or adverse outcomes reported. Immunotherapy has shown positive results as an effective treatment option for unresectable, recurrent, or metastatic CSCC. It is currently approved for use in the USA and Europe.
引用
收藏
页码：1156 / 1165
页数：10
相关论文
共 50 条
  • [41] Nivolumab immunotherapy rechallenge for progressive laryngeal squamous cell carcinoma after failure of conventional treatment: A CARE case report
    Gervais, C.
    Auclin, E.
    Saltel-Fulero, A.
    Clair, G.
    Oudard, S.
    Mirghani, H.
    EUROPEAN ANNALS OF OTORHINOLARYNGOLOGY-HEAD AND NECK DISEASES, 2024, 141 (04) : 231 - 234
  • [42] Multidisciplinary management of locally advanced and metastatic cutaneous squamous cell carcinoma
    Claveau, J.
    Archambault, J.
    Ernst, D. S.
    Giacomantonio, C.
    Limacher, J. J.
    Murray, C.
    Parent, F.
    Zloty, D.
    CURRENT ONCOLOGY, 2020, 27 (04) : E399 - E407
  • [43] Anti-PD-1 therapy using cemiplimab for advanced cutaneous squamous cell carcinoma in HIV patient: A case report
    Alloghbi, Abdurahman
    Ninia, James
    Alshare, Bayan
    Hotaling, Jeffrey
    Raza, Syed
    Sukari, Ammar
    CLINICAL CASE REPORTS, 2021, 9 (12):
  • [44] Durable complete response to early immunotherapy discontinuation in a kidney transplant recipient with advanced cutaneous squamous cell carcinoma: A case report and review of literature
    Lu, Ziyao
    Afzal, Muhammad
    Shirai, Keisuke
    TRANSPLANT IMMUNOLOGY, 2023, 81
  • [45] Combination regimens and immunologic mechanisms to enhance the efficacy of cemiplimab for cutaneous squamous cell carcinoma
    Hanania, Hannah L.
    Lewis, Daniel J.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2022, 22 (02) : 237 - 238
  • [46] A phase 2 study of first-line nivolumab in patients with locally advanced or metastatic cutaneous squamous-cell carcinoma
    Munhoz, Rodrigo R.
    Nader-Marta, Guilherme
    de Camargo, Veridiana P.
    Queiroz, Marcello M.
    Cury-Martins, Jade
    Ricci, Herminia
    de Mattos, Marcela R.
    de Menezes, Thiago A. F.
    Machado, Guilherme U. C.
    Bertolli, Eduardo
    Barros, Milton
    de Souza, Carina E.
    Franke, Fabio
    Ferreira, Fabio O.
    Feher, Olavo
    de Castro Jr, Gilberto
    CANCER, 2022, 128 (24) : 4223 - 4231
  • [47] Alpelisib and Immunotherapy: A Promising Combination for Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck
    Suleiman, Riham
    McGarrah, Patrick
    Baral, Binav
    Owen, Dawn
    Aguilera, Jesus Vera
    Halfdanarson, Thor R.
    Price, Katharine A.
    Bayne, Harry E. Fuentes
    CANCER REPORTS, 2024, 7 (10)
  • [48] Response to Valerio Nardone et al's "Previous radiotherapy increases the efficacy of cemiplimab in the treatment of locally advanced and metastatic cutaneous squamous cell carcinoma: A retrospective analysis"
    Sajid, Syeda Laiba
    Rehman, Muhammad Aizaz ur
    Sajid, Syeda Akifa
    Shahid, Nayab
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2025, 92 (03) : e53 - e54
  • [49] Efficacy of nivolumab in the treatment of metastatic cutaneous squamous cell carcinoma in a kidney-transplant patient with a history of allograft rejection
    Bastos, S.
    Masmoudi, W.
    Pinard, C.
    Duval-Modeste, A. -B.
    Joly, P.
    Hebert, V.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2022, 149 (03): : 198 - 199
  • [50] Recent Advances in Immunotherapy for Patients with Head and Neck Cutaneous Squamous Cell Carcinoma
    Khorasanchi, Adam
    Wu, Richard
    Kendra, Kari
    Verschraegen, Claire
    CANCERS, 2022, 14 (21)
12345